Cargando…

Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants

Therapeutic performance of recombinant antibodies relies on two independent mechanisms: antigen recognition and Fc-mediated antibody effector functions. Interaction of Fc-fragment with different FcR triggers antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity and determine...

Descripción completa

Detalles Bibliográficos
Autores principales: Dashivets, Tetyana, Thomann, Marco, Rueger, Petra, Knaupp, Alexander, Buchner, Johannes, Schlothauer, Tilman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676693/
https://www.ncbi.nlm.nih.gov/pubmed/26657484
http://dx.doi.org/10.1371/journal.pone.0143520
_version_ 1782405219487842304
author Dashivets, Tetyana
Thomann, Marco
Rueger, Petra
Knaupp, Alexander
Buchner, Johannes
Schlothauer, Tilman
author_facet Dashivets, Tetyana
Thomann, Marco
Rueger, Petra
Knaupp, Alexander
Buchner, Johannes
Schlothauer, Tilman
author_sort Dashivets, Tetyana
collection PubMed
description Therapeutic performance of recombinant antibodies relies on two independent mechanisms: antigen recognition and Fc-mediated antibody effector functions. Interaction of Fc-fragment with different FcR triggers antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity and determines longevity of the antibody in serum. In context of therapeutic antibodies FcγRs play the most important role. It has been demonstrated that the Fc-attached sugar moiety is essential for IgG effector functionality, dictates its affinity to individual FcγRs and determines binding to different receptor classes: activating or inhibitory. In this study, we systematically analyze effector functions of monoclonal IgG1 and its eight enzymatically engineered glycosylation variants. The analysis of interaction of glycovariants with FcRs was performed for single, as well as for antigen-bound antibodies and IgGs in a form of immune complex. In addition to functional properties we addressed impact of glycosylation on the structural properties of the tested glycovariants. We demonstrate a clear impact of glycosylation pattern on antibody stability and interaction with different FcγRs. Consistent with previous reports, deglycosylated antibodies failed to bind all Fcγ-receptors, with the exception of high affinity FcγRI. The FcγRII and FcγRIIIa binding activity of IgG1 was observed to depend on the galactosylation level, and hypergalactosylated antibodies demonstrated increased receptor interaction. Sialylation did not decrease the FcγR binding of the tested IgGs; in contrast, sialylation of antibodies improved binding to FcγRIIa and IIb. We demonstrate that glycosylation influences to some extent IgG1 interaction with FcRn. However, independent of glycosylation pattern the interaction of IgG1 with a soluble monomeric target surprisingly resulted in an impaired receptor binding. Here, we demonstrate, that immune complexes (IC), induced by multimeric ligand, compensated for the decreased affinity of target bound antibody towards FcRs, showing the importance of the IC-formation for the FcR- mediated effector functions.
format Online
Article
Text
id pubmed-4676693
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-46766932015-12-31 Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants Dashivets, Tetyana Thomann, Marco Rueger, Petra Knaupp, Alexander Buchner, Johannes Schlothauer, Tilman PLoS One Research Article Therapeutic performance of recombinant antibodies relies on two independent mechanisms: antigen recognition and Fc-mediated antibody effector functions. Interaction of Fc-fragment with different FcR triggers antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity and determines longevity of the antibody in serum. In context of therapeutic antibodies FcγRs play the most important role. It has been demonstrated that the Fc-attached sugar moiety is essential for IgG effector functionality, dictates its affinity to individual FcγRs and determines binding to different receptor classes: activating or inhibitory. In this study, we systematically analyze effector functions of monoclonal IgG1 and its eight enzymatically engineered glycosylation variants. The analysis of interaction of glycovariants with FcRs was performed for single, as well as for antigen-bound antibodies and IgGs in a form of immune complex. In addition to functional properties we addressed impact of glycosylation on the structural properties of the tested glycovariants. We demonstrate a clear impact of glycosylation pattern on antibody stability and interaction with different FcγRs. Consistent with previous reports, deglycosylated antibodies failed to bind all Fcγ-receptors, with the exception of high affinity FcγRI. The FcγRII and FcγRIIIa binding activity of IgG1 was observed to depend on the galactosylation level, and hypergalactosylated antibodies demonstrated increased receptor interaction. Sialylation did not decrease the FcγR binding of the tested IgGs; in contrast, sialylation of antibodies improved binding to FcγRIIa and IIb. We demonstrate that glycosylation influences to some extent IgG1 interaction with FcRn. However, independent of glycosylation pattern the interaction of IgG1 with a soluble monomeric target surprisingly resulted in an impaired receptor binding. Here, we demonstrate, that immune complexes (IC), induced by multimeric ligand, compensated for the decreased affinity of target bound antibody towards FcRs, showing the importance of the IC-formation for the FcR- mediated effector functions. Public Library of Science 2015-12-11 /pmc/articles/PMC4676693/ /pubmed/26657484 http://dx.doi.org/10.1371/journal.pone.0143520 Text en © 2015 Dashivets et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Dashivets, Tetyana
Thomann, Marco
Rueger, Petra
Knaupp, Alexander
Buchner, Johannes
Schlothauer, Tilman
Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants
title Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants
title_full Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants
title_fullStr Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants
title_full_unstemmed Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants
title_short Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants
title_sort multi-angle effector function analysis of human monoclonal igg glycovariants
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676693/
https://www.ncbi.nlm.nih.gov/pubmed/26657484
http://dx.doi.org/10.1371/journal.pone.0143520
work_keys_str_mv AT dashivetstetyana multiangleeffectorfunctionanalysisofhumanmonoclonaliggglycovariants
AT thomannmarco multiangleeffectorfunctionanalysisofhumanmonoclonaliggglycovariants
AT ruegerpetra multiangleeffectorfunctionanalysisofhumanmonoclonaliggglycovariants
AT knauppalexander multiangleeffectorfunctionanalysisofhumanmonoclonaliggglycovariants
AT buchnerjohannes multiangleeffectorfunctionanalysisofhumanmonoclonaliggglycovariants
AT schlothauertilman multiangleeffectorfunctionanalysisofhumanmonoclonaliggglycovariants